glycopyrrolate

Generic: glycopyrrolate

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name glycopyrrolate
Generic Name glycopyrrolate
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

glycopyrrolate .2 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1425
Product ID 51662-1425_2b382c02-1322-a447-e063-6394a90ac5c1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208973
Listing Expiration 2026-12-31
Marketing Start 2019-12-21

Pharmacologic Class

Classes
anticholinergic [epc] cholinergic antagonists [moa] cholinergic muscarinic antagonist [epc] cholinergic muscarinic antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621425
Hyphenated Format 51662-1425

Supplemental Identifiers

RxCUI
238212 1731582
UPC
0370121139614 0370121139416
UNII
V92SO9WP2I

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name glycopyrrolate (source: ndc)
Generic Name glycopyrrolate (source: ndc)
Application Number ANDA208973 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • .2 mg/mL
source: ndc
Packaging
  • 1 mL in 1 VIAL (51662-1425-1)
source: ndc

Packages (1)

51662-1425-1 1 mL in 1 VIAL (51662-1425-1)

Ingredients (1)

glycopyrrolate (.2 mg/mL)

Linked Drug Pages (1)

GLYCOPYRROLATE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "2b382c02-1322-a447-e063-6394a90ac5c1", "openfda": {"upc": ["0370121139614", "0370121139416"], "unii": ["V92SO9WP2I"], "rxcui": ["238212", "1731582"], "spl_set_id": ["9a3a142c-daaf-79af-e053-2995a90a1c51"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL (51662-1425-1)", "package_ndc": "51662-1425-1", "marketing_start_date": "20191221"}], "brand_name": "GLYCOPYRROLATE", "product_id": "51662-1425_2b382c02-1322-a447-e063-6394a90ac5c1", "dosage_form": "INJECTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "51662-1425", "generic_name": "GLYCOPYRROLATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GLYCOPYRROLATE", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "ANDA208973", "marketing_category": "ANDA", "marketing_start_date": "20191221", "listing_expiration_date": "20261231"}